Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2
Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Pharmaxis Ltd (Pharmaxis) is a research company that develops and commercialize healthcare products. The company offers products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves lung function and relieves the mucus burden in the lungs of patients. Its products pipeline includes orbital dry powder inhaler, PXS-4728A, LOXL-2 and ASM8. The company's ASM8 product is used in the treatment of asthma, and orbital dry powder inhailer is used to deliver high dosage drugs to the respiratory tract. It specializes in cystic fibrosis, bronchiectasis, asthma and chronic obstructive pulmonary disease (COPD), and inflammatory and fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and pulmonary fibrosis. Pharmaxis is headquartered in Frenchs Forest, New South Wales, Australia. Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions. GlobalData derived the data presented in this report from proprietary in-house Pharma etrack deals database, and primary and secondary research. Scope - Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. 3
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Additional Details Publisher : Global Data Reference : GDPH63500D Number of Pages : 29 Report Format : PDF Publisher Information : 4
5
Table Of Contents for Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Table of Contents Table of Contents 2List of Tables 3List of Figures 4Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5Pharmaxis Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8Pharmaxis Ltd, Medical Devices Deals, 2010 to YTD 2016 9Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deal Details 11Partnerships 11Pharmaxis Enters into Partnership with Synairgen 11Pharmaxis Enters into Distribution Agreement with Chiesi Farmaceutici 12Pharmaxis Enters into Distribution Agreement with Chiesi Farmaceutici for Bronchitol in US 13Pharmaxis Enters Into Distribution Agreement With PharmaSwiss For Bronchitol 14Quintiles Transnational Enters Into Co-Marketing Agreement With Pharmaxis 15Equity Offering 17Pharmaxis Announces Second Tranche Of Private Placement Of Shares For US$20 Million 17Pharmaxis Completes Second Tranche Of Private Placement Of Common Stock For US$7 Million 18Pharmaxis Completes Second Tranche Of Rights Issue Of Common Stock For US$16.6 Million 20Asset Transactions 22Boehringer Ingelheim Acquires Anti-Inflammatory Drug Candidate from Pharmaxis 22Acquisition 24Pharmaxis Acquires Topigen Pharma 24Pharmaxis Ltd - Key Competitors 26Key Employees 27Locations And Subsidiaries 28Head Office 28Other Locations & Subsidiaries 28Appendix 29Methodology 29About GlobalData 29Contact Us 29Disclaimer 29 6
List Of Tables in Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Tables Pharmaxis Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 1 Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Pharmaxis Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6 Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Pharmaxis Ltd, Deals By Therapy Area, 2010 to YTD 2016 8 Pharmaxis Ltd, Medical Devices Deals, 2010 to YTD 2016 9 Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10 Pharmaxis Enters into Partnership with Synairgen 11 Pharmaxis Enters into Distribution Agreement with Chiesi Farmaceutici 12 Pharmaxis Enters into Distribution Agreement with Chiesi Farmaceutici for Bronchitol in US 13 Pharmaxis Enters Into Distribution Agreement With PharmaSwiss For Bronchitol 14 Quintiles Transnational Enters Into Co-Marketing Agreement With Pharmaxis 15 Pharmaxis Announces Second Tranche Of Private Placement Of Shares For US$20 Million 17 Pharmaxis Completes Second Tranche Of Private Placement Of Common Stock For US$7 Million 18 Pharmaxis Completes Second Tranche Of Rights Issue Of Common Stock For US$16.6 Million 20 Boehringer Ingelheim Acquires Anti-Inflammatory Drug Candidate from Pharmaxis 22 Pharmaxis Acquires Topigen Pharma 24 Pharmaxis Ltd, Key Competitors 26 Pharmaxis Ltd, Key Employees 27 Pharmaxis Ltd, Subsidiaries 28 7
List Of Figures, Charts and Diagrams in Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile List of Figures Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1 Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1 Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1 Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1 Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5 Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6 Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7 Pharmaxis Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8 Pharmaxis Ltd, Medical Devices Deals, 2010 to YTD 2016 9 8
How to Buy... Pharmaxis Ltd (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $250 Single User Price $500 Site License Price $750 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 9